Rating History for Galmed Pharmaceuticals (GLMD) by Canaccord

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/8/2022 Edward Nash Downgrade Hold
(Buy)
1.00
(5.00)
0.44
(0.68)
54.55% Details